Abi Siva, Associate Professor, Director at Medical Oncology, shared a post on X:
“Proud to see my fellow presenting key work at SABCS25 on Oncotype DX–MammaPrint discordance.
Occurs ~35% when both ordered. Interesting patterns in chemo decisions when results conflict.”
More posts about SABCS 2025 on OncoDaily.
You Can Also Read:
15 Posts Not to Miss from SABCS 2025, Part 1
20 Posts Not to Miss from SABCS 2025, Part 2
25 Posts Not to Miss from SABCS 2025, Part 3
